How could rapid bacterial identification improve the management of septic patients?

Expert Review of Anti-Infective Therapy

Volumn 9, Issue 9, 2011, Pages 707-709

  Emonet, Stéphane ^a   Schrenzel, Jacques ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

bacterial identification; patient management; rapid diagnosis; sepsis; smart incubators; targeted antimicrobial therapy

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; BACTERIAL DNA; CLARITHROMYCIN; COTRIMOXAZOLE; FLUCONAZOLE; IMIPENEM; MACROLIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VALACICLOVIR; VANCOMYCIN;

ADULT RESPIRATORY DISTRESS SYNDROME; AGRANULOCYTOSIS; ANTIBIOTIC SENSITIVITY; BACTERIAL INFECTION; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BLOOD CULTURE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DNA DETERMINATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EARLY INTERVENTION; ELECTROSPRAY MASS SPECTROMETRY; ESCHERICHIA COLI; FLUORESCENCE IN SITU HYBRIDIZATION; FUSOBACTERIUM NECROPHORUM; HUMAN; INTENSIVE CARE; LABORATORY TEST; LEMIERRE SYNDROME; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MICROARRAY ANALYSIS; MICROBIOLOGICAL EXAMINATION; MULTIDRUG RESISTANCE; PATIENT CARE; PNEUMONIA; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; PRESCRIPTION; PSEUDOMONAS AERUGINOSA; REVIEW; SEPSIS; SHOCK; STENOTROPHOMONAS MALTOPHILIA;

ANTI-BACTERIAL AGENTS; BIOLOGICAL ASSAY; DRUG RESISTANCE, MULTIPLE, BACTERIAL; EARLY DIAGNOSIS; FUSOBACTERIUM NECROPHORUM; HOST SPECIFICITY; HUMANS; POLYMERASE CHAIN REACTION; PSEUDOMONAS AERUGINOSA; SHOCK, SEPTIC; STENOTROPHOMONAS MALTOPHILIA; TIME FACTORS;

EID: 80052755161     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/eri.11.84     Document Type: Review

References (17)

1. Ferroni A, Suarez S, Beretti JL, Dauphin B, Bille E, Meyer J et al. Real-time identification of bacteria and Candida species in positive blood culture broths by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J. Clin. Microbiol. 48(5), 1542-1548 (2010).
2. Poppert S, Riecker M, Wellinghausen N, Frickmann H, Essig A. Accelerated identification of Staphylococcus aureus from blood cultures by a modified fluorescence in situ hybridization procedure. J. Med. Microbiol. 59(Pt 1), 65-68 (2010).
3. Cattoir V, Merabet L, Djibo N, Rioux C, Legrand P, Girou E et al. Clinical impact of a real-time PCR assay for rapid identification of Staphylococcus aureus and determination of methicillin resistance from positive blood cultures. Clin. Microbiol. Infect. 17(3), 425-431 (2011).
4. Drancourt M. Detection of microorganisms in blood specimens using MALDI-TOF mass spectrometry: a review. Clin. Microbiol. Infect. 16(11), 1620-1625 (2010).
5. Palka-Santini M, Putzfeld S, Cleven BE, Kronke M, Krut O. Rapid identification, virulence analysis and resistance profiling of Staphylococcus aureus by gene segment-based DNA microarrays: application to blood culture post-processing. J. Microbiol. Methods 68(3), 468-477 (2007). (Pubitemid 46329149)
6. Westh H, Lisby G, Breysse F et al. Multiplex real-time PCR and blood culture for identification of bloodstream pathogens in patients with suspected sepsis. Clin. Microbiol. Infect. 15(6), 544-551 (2009).
7. Ecker DJ, Sampath R, Massire C et al. Ibis T5000: a universal biosensor approach for microbiology. Nat. Rev. Microbiol. 6(7), 553-558 (2008). (Pubitemid 351850978)
8. Emonet S, Shah HN, Cherkaoui A, Schrenzel J. Application and use of various mass spectrometry methods in clinical microbiology. Clin. Microbiol. Infect. 16(11), 1604-1613 (2010).
9. Ecker DJ, Sampath R, Li H et al. New technology for rapid molecular diagnosis of bloodstream infections. Expert Rev. Mol. Diagn. 10(4), 399-415 (2010).
10. Bouza E, Sousa D, Rodriguez-Creixems M, Lechuz JG, Munoz P. Is the volume of blood cultured still a significant factor in the diagnosis of bloodstream infections? J. Clin. Microbiol. 45(9), 2765-2769 (2007). (Pubitemid 47417312)
11. Zubert S, Funk DJ, Kumar A. Antibiotics in sepsis and septic shock: like everything else in life, timing is everything. Crit. Care Med. 38(4), 1211-1212 (2010).
12. Kumar A, Ellis P, Arabi Y, Roberts D, Light B, Parrillo JE et al. Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock. Chest 136(5), 1237-1248 (2009).
13. Markogiannakis A, Fildisis G, Tsiplakou S et al. Cross-transmission of multidrug-resistant Acinetobacter baumannii clonal strains causing episodes of sepsis in a trauma intensive care unit. Infect. Control Hosp. Epidemiol. 29(5), 410-417 (2008). (Pubitemid 351589975)
14. Consales G, Gramigni E, Zamidei L, Bettocchi D, De Gaudio AR. A multidrug-resistant Acinetobacter baumannii outbreak in intensive care unit: Antimicrobial and organizational strategies. J. Crit. Care DOI:101016/j.jcrc. 201012016 (2011) (Epub ahead of print).
15. Gao H, Evans TW, Finney SJ. Bench-to-bedside review: sepsis, severe sepsis and septic shock - does the nature of the infecting organism matter? Crit. Care 12(3), 213 (2008).
16. Bauer KA, West JE, Balada-Llasat JM, Pancholi P, Stevenson KB, Goff DA. An antimicrobial stewardship program's impact with rapid polymerase chain reaction methicillin-resistant Staphylococcus aureus/S. aureus blood culture test in patients with S. aureus bacteremia. Clin. Infect. Dis. 51(9), 1074-1080 (2010).
17. Schrenzel J. PCR for the diagnosis of sepsis: hope or hype? Crit. Care 15(1), 111 (2011).